article thumbnail

BMF Biotechnology Launches 3D Printed Organ-On-A-Chip Platform to Accelerate Life Sciences Research

HIT Consultant

What You Should Know; – Boston Micro Fabrication (BMF) today announced the launch of BMF Biotechnology Inc., Expanding Beyond Printing: The Rise of BMF Biotechnology In late 2022, BMF embarked on a strategic expansion. The initial phase of research has yielded highly promising results.

article thumbnail

Biotechnology and Today's Warfighter

The Rand Blog

Biotechnology has a broad and often misunderstood scope, one with significant implications for today's warfighter, and it may be reaching a critical junction. As it continues to mature, proactive policy becomes necessary for the federal government to leverage emerging capabilities effectively and remain competitive.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The Fierce 50 of 2024

Fierce Healthcare

I’m honored to introduce the second edition of the Fierce 50, where we once again spotli | In this year's Fierce 50 special report, we are highlighting the innovators and leaders who are shaping the future of healthcare, pharma and biotechnology.

article thumbnail

Artificial Intelligence and Biotechnology: Risks and Opportunities

The Rand Blog

Machine learning is helping scientists make sense of the genetic keys that could unlock new crops, new drugs, and vaccines. But policymakers may not be prepared for the impact those two fields could have together. To make the most of the opportunities to come, and to avoid the dangers, that has to change.

article thumbnail

FTC’s Proposed Non-Compete Rule: A Step in the Right Direction for Health Care and Biotechnology

Bill Of Health

Banning non-compete clauses may help to promote competition and innovation in biotechnology and health care. Currently, there is a high degree of knowledge concentration in new and evolving technologies in the biotechnology sector.

article thumbnail

GPs cry My Health Record 'overhaul' and more briefs

Healthcare It News

Biotechnology company Amgen Australia has backed its development. It exports detailed psoriasis patient lists, which are categorised by severity and treatment type. The dashboard is also informed by the updated Australian consensus on treating moderate to severe psoriasis.

article thumbnail

Range Biotechnologies Raises $5.2M to Advance Proteomics for Precision Health

HIT Consultant

What You Should Know: Range Biotechnologies (Range Bio) announced $5.2M in seed funding, led by TechBio-focused ARTIS Ventures with participation from Pear VC , Page One Ventures , Civilization Ventures , Pillar , Four Cities Capital , Hawktail , and others.